|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on May 04, 2012 |
Title |
MiR-27a-3p in peripheral blood mononuclear cells as a potential marker for pancreatic cancer screening |
Organism |
Homo sapiens |
Experiment type |
Non-coding RNA profiling by high throughput sequencing
|
Summary |
Background & Aims: MicroRNAs have been shown to offer great potential in the diagnosis of cancer. We aimed to identify microRNAs in peripheral blood mononuclear cells (PBMCs) for diagnosing pancreatic cancer (PC). Methods: PBMCs microRNA expression was investigated in three independent cohorts including 352 participants (healthy, benign pancreatic/peripancreatic diseases (BPD), and PC). First, we used sequencing technology to identify differentially expressed microRNAs in 60 PBMCs samples for diagnosing PC. Quantitative reverse-transcriptase polymerase chain reaction assay was then applied to evaluate the expression of selected microRNAs. A logistic regression model was constructed using an independent cohort. Area under the receiver operating characteristic curve (AUC) was used to evaluate diagnostic accuracy. Results: We found that PBMCs miR-27a-3p could efficiently discriminate PC from BPD (AUC=0.840; 95% CI, 0.787 to 0.885; sensitivity=82.2%, specificity=76.7%). A panel composed of PBMCs miR-27a-3p and serum CA19-9 provided a high diagnostic accuracy in differentiating PC from BPD in the clinical setting (AUC=0.886; 95% CI, 0.837 to 0.923; sensitivity=85.3%, specificity=81.6%). The satisfactory diagnostic performance of the panel persisted regardless of disease status (AUCs for tumour-node-metastasis stagesⅠ,Ⅱ, and Ⅲ were 0.881, 0.884, and 0.893, respectively). Conclusion: PBMCs miR-27a-3p could be a potential marker for PC screening. A panel composed of PBMCs miR-27a-3p and serum CA19-9 has considerable clinical value in diagnosing early-stage PC. Therefore, patients who would have otherwise missed the curative treatment window can benefit from optimal therapy.
|
|
|
Overall design |
Examination of different MicroRNA profiles in 3 types of PBMCs samples
|
|
|
Contributor(s) |
Wang W, Liu L, Li G, Chen Y, Li C, Jin D, Wang X |
Citation(s) |
23430754 |
Submission date |
May 02, 2012 |
Last update date |
May 15, 2019 |
Contact name |
xiaolin wang |
E-mail(s) |
wwsdj2002@163.com
|
Organization name |
Zhongshan Hospital, Fudan University
|
Street address |
180 Feng Lin Rd
|
City |
Shanghai |
ZIP/Postal code |
200032 |
Country |
China |
|
|
Platforms (1) |
GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
|
Samples (3) |
|
Relations |
SRA |
SRP012608 |
BioProject |
PRJNA163233 |
Supplementary file |
Size |
Download |
File type/resource |
GSE37710_BPD-Healthy.express.txt.gz |
15.5 Kb |
(ftp)(http) |
TXT |
GSE37710_BPD-PDAC.express.txt.gz |
14.9 Kb |
(ftp)(http) |
TXT |
GSE37710_PDAC-Healthy.express.txt.gz |
15.5 Kb |
(ftp)(http) |
TXT |
SRA Run Selector |
Processed data are available on Series record |
Raw data are available in SRA |
|
|
|
|
|